A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC)

Oxaliplatin immune-induced syndrome (OIIS) was recently recognized as an uncommon complication of oxaliplatin therapy.

Bibliographic Details
Main Authors:	Ezanno Anne-Cecile, Malgras Brice, Aoun Olivier, Delarge Amaury, Doreille Alice, Pocard Marc
Format:	Article
Language:	English
Published:	De Gruyter 2022-01-01
Series:	Pleura and Peritoneum
Subjects:	colorectal cancer drug reaction hypersensitivity reaction oxaliplatin oxaliplatin immune-induced syndrome (oiis) pipac
Online Access:	https://doi.org/10.1515/pp-2021-0138

Internet

https://doi.org/10.1515/pp-2021-0138